Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
Cephalalgia : an International Journal of Headache
|
July 10, 2018
Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study
Messoud Ashina, Stewart Tepper, Jan Lewis Brandes, et al.
Cephalalgia : an International Journal of Headache
|
February 24, 2018
ARISE: A Phase 3 randomized trial of erenumab for episodic migraine
David W Dodick, Messoud Ashina, Jan Lewis Brandes, et al.
Journal of Clinical Medicine
|
March 29, 2023
Femoral Anteversion in Total Hip Arthroplasty: Retrospective Comparison of Short- and Straight-Stem Models Using CT Scans
Sebastian Martin Klim, Patrick Reinbacher, Maria Anna Smolle, et al.
Cancer Epidemiology
|
June 12, 2017
Clinical outcomes of female breast cancer according to BRCA mutation status
Deirdre P Cronin-Fenton, Anders Kjærsgaard, Mette Nørgaard, et al.
JAMA
|
April 5, 2007
Sumatriptan-naproxen for acute treatment of migraine: a randomized trial
Jan Lewis Brandes, David Kudrow, Stuart R Stark, et al.
Neurology
|
April 19, 2019
Erenumab in chronic migraine with medication overuse: Subgroup analysis of a randomized trial
Stewart J Tepper, Hans-Christoph Diener, Messoud Ashina, et al.
Cephalalgia : an International Journal of Headache
|
December 10, 2019
The spectrum of response to erenumab in patients with chronic migraine and subgroup analysis of patients achieving ≥50%, ≥75%, and 100% response
Jan Lewis Brandes, Hans-Christoph Diener, David Dolezil, et al.
Headache
|
May 20, 2022
Long-term efficacy and safety of erenumab in patients with chronic migraine in whom prior preventive treatments had failed: A subgroup analysis
Messoud Ashina, Stewart J Tepper, Jan Lewis Brandes, et al.
Prevention Science : the Official Journal of the Society for Prevention Research
|
July 9, 2013
Quasi-experimental pilot study of intervention to increase participant retention and completed home visits in the nurse-family partnership
Erin M Ingoldsby, Pilar Baca, Maureen W McClatchey, et al.
Clinical Breast Cancer
|
December 26, 2017
A European, Observational Study of Endocrine Therapy Administration in Patients With an Initial Diagnosis of Hormone Receptor-Positive Advanced Breast Cancer
Esther Bastiaannet, Jackie Charman, Tom Børge Johannesen, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
Cephalalgia : an International Journal of Headache
|
July 10, 2018
Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study
Messoud Ashina, Stewart Tepper, Jan Lewis Brandes, et al.
Cephalalgia : an International Journal of Headache
|
February 24, 2018
ARISE: A Phase 3 randomized trial of erenumab for episodic migraine
David W Dodick, Messoud Ashina, Jan Lewis Brandes, et al.
Journal of Clinical Medicine
|
March 29, 2023
Femoral Anteversion in Total Hip Arthroplasty: Retrospective Comparison of Short- and Straight-Stem Models Using CT Scans
Sebastian Martin Klim, Patrick Reinbacher, Maria Anna Smolle, et al.
Cancer Epidemiology
|
June 12, 2017
Clinical outcomes of female breast cancer according to BRCA mutation status
Deirdre P Cronin-Fenton, Anders Kjærsgaard, Mette Nørgaard, et al.
JAMA
|
April 5, 2007
Sumatriptan-naproxen for acute treatment of migraine: a randomized trial
Jan Lewis Brandes, David Kudrow, Stuart R Stark, et al.
Neurology
|
April 19, 2019
Erenumab in chronic migraine with medication overuse: Subgroup analysis of a randomized trial
Stewart J Tepper, Hans-Christoph Diener, Messoud Ashina, et al.
Cephalalgia : an International Journal of Headache
|
December 10, 2019
The spectrum of response to erenumab in patients with chronic migraine and subgroup analysis of patients achieving ≥50%, ≥75%, and 100% response
Jan Lewis Brandes, Hans-Christoph Diener, David Dolezil, et al.
Headache
|
May 20, 2022
Long-term efficacy and safety of erenumab in patients with chronic migraine in whom prior preventive treatments had failed: A subgroup analysis
Messoud Ashina, Stewart J Tepper, Jan Lewis Brandes, et al.
Prevention Science : the Official Journal of the Society for Prevention Research
|
July 9, 2013
Quasi-experimental pilot study of intervention to increase participant retention and completed home visits in the nurse-family partnership
Erin M Ingoldsby, Pilar Baca, Maureen W McClatchey, et al.
Clinical Breast Cancer
|
December 26, 2017
A European, Observational Study of Endocrine Therapy Administration in Patients With an Initial Diagnosis of Hormone Receptor-Positive Advanced Breast Cancer
Esther Bastiaannet, Jackie Charman, Tom Børge Johannesen, et al.
Page
of 4